{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T16:00:04Z","timestamp":1776960004943,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,3,13]],"date-time":"2010-03-13T00:00:00Z","timestamp":1268438400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2010,3,13]],"date-time":"2010-03-13T00:00:00Z","timestamp":1268438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>A subgroup of patients with primary Sj\u00f6gren's Syndrome (SS) and positive anticentromere antibodies (ACA) were recognized as having features intermediate between SS and systemic sclerosis (SSc). Our goal was to describe this group clinically and serologically and define its tendency to evolve to full blown SSc.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Among 535 patients with primary SS we identified 20 ACA positive (ACA+\/SS). We compared them to 61 randomly selected ACA negative SS patients (ACA-\/SS), 31 ACA positive SSc patients with sicca manifestations [SSc\/(+) sicca] and 20 ACA positive SSc patients without sicca manifestations [SSc\/(-) sicca].<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Prevalence of ACA among SS patients was 3.7%. Cases and controls did not differ in sex ratio and age at disease onset. ACA+\/SS patients had a lower prevalence of dry eyes, hypergammaglobulinaemia, anti-Ro and anti-La antibodies and a higher prevalence of Raynaud's phenomenon and dysphagia compared to ACA-\/SS patients. They also had lower prevalence of telangiectasias, puffy fingers, sclerodactyly, Raynaud's phenomenon, digital ulcers and gastroesophageal reflux in comparison to both of the SSc subgroups and a lower prevalence of dyspnoea and lung fibrosis compared to the SSc\/(+) sicca subgroup. Two patients originally having ACA+\/SS evolved to full blown SSc. Four deaths occurred, all among SSc patients. Kaplan Meier analysis showed a significant difference between cases and controls in time from disease onset to development of gastroesophageal reflux, telangiectasias, digital ulcers, arthritis, puffy fingers, xerostomia, hypergammaglobulinaemia and dysphagia.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>ACA+\/SS has a clinical phenotype intermediate between ACA-\/SS and SSc and shows little tendency to evolve to SSc.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/ar2958","type":"journal-article","created":{"date-parts":[[2010,3,19]],"date-time":"2010-03-19T19:14:54Z","timestamp":1269026094000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Anticentromere antibody positive Sj\u00f6gren's Syndrome: a retrospective descriptive analysis"],"prefix":"10.1186","volume":"12","author":[{"given":"Vasiliki-Kalliopi K","family":"Bournia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantina D","family":"Diamanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panayiotis G","family":"Vlachoyiannopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haralampos M","family":"Moutsopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,13]]},"reference":[{"key":"2793_CR1","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1001\/archinte.164.12.1275","volume":"164","author":"SS Kassan","year":"2004","unstructured":"Kassan SS, Moutsopoulos HM: Clinical manifestations and early diagnosis of Sjogren syndrome. Arch Intern Med. 2004, 164: 1275-1284. 10.1001\/archinte.164.12.1275.","journal-title":"Arch Intern Med"},{"key":"2793_CR2","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/rheumatology\/35.3.204","volume":"35","author":"HM Moutsopoulos","year":"1996","unstructured":"Moutsopoulos HM, Kordossis T: Sjogren's syndrome revisited: autoimmune epithelitis. Br J Rheumatol. 1996, 35: 204-206. 10.1093\/rheumatology\/35.3.204.","journal-title":"Br J Rheumatol"},{"key":"2793_CR3","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.rdc.2008.08.009","volume":"34","author":"E Theander","year":"2008","unstructured":"Theander E, Jacobsson LT: Relationship of Sjogren's syndrome to other connective tissue and autoimmune disorders. Rheum Dis Clin North Am. 2008, 34: 935-947. 10.1016\/j.rdc.2008.08.009. viii-ix","journal-title":"Rheum Dis Clin North Am"},{"key":"2793_CR4","first-page":"1488","volume":"32","author":"S Miyawaki","year":"2005","unstructured":"Miyawaki S, Asanuma H, Nishiyama S, Yoshinaga Y: Clinical and serological heterogeneity in patients with anticentromere antibodies. J Rheumatol. 2005, 32: 1488-1494.","journal-title":"J Rheumatol"},{"key":"2793_CR5","first-page":"2253","volume":"34","author":"C Salliot","year":"2007","unstructured":"Salliot C, Gottenberg JE, Bengoufa D, Desmoulins F, Miceli-Richard C, Mariette X: Anticentromere antibodies identify patients with Sjogren's syndrome and autoimmune overlap syndrome. J Rheumatol. 2007, 34: 2253-2258.","journal-title":"J Rheumatol"},{"key":"2793_CR6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/rheumatology\/32.4.297","volume":"32","author":"PG Vlachoyiannopoulos","year":"1993","unstructured":"Vlachoyiannopoulos PG, Drosos AA, Wiik A, Moutsopoulos HM: Patients with anticentromere antibodies, clinical features, diagnoses and evolution. Br J Rheumatol. 1993, 32: 297-301. 10.1093\/rheumatology\/32.4.297.","journal-title":"Br J Rheumatol"},{"key":"2793_CR7","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH: Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002, 61: 554-558. 10.1136\/ard.61.6.554.","journal-title":"Ann Rheum Dis"},{"key":"2793_CR8","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/art.1780230510","volume":"23","author":"AT Masi","year":"1980","unstructured":"Masi AT, Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980, 23: 581-590. 10.1002\/art.1780230510.","journal-title":"Arthritis Rheum"},{"key":"2793_CR9","first-page":"1573","volume":"28","author":"EC LeRoy","year":"2001","unstructured":"LeRoy EC, Medsger TA: Criteria for the classification of early systemic sclerosis. J Rheumatol. 2001, 28: 1573-1576.","journal-title":"J Rheumatol"},{"key":"2793_CR10","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1136\/ard.2008.106302","volume":"68","author":"M Matucci-Cerinic","year":"2009","unstructured":"Matucci-Cerinic M, Allanore Y, Czirjak L, Tyndall A, Muller-Ladner U, Denton C, Valentini G, Distler O, Fligelstone K, Tyrrel-Kennedy A, Farge D, Kowal-Bielecka O, Hoogen van den F, Cutolo M, Sampaio-Barros PD, Nash P, Takehara K, Furst DE: The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy. Ann Rheum Dis. 2009, 68: 1377-1380. 10.1136\/ard.2008.106302.","journal-title":"Ann Rheum Dis"},{"key":"2793_CR11","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1136\/jcp.21.5.656","volume":"21","author":"DM Chisholm","year":"1968","unstructured":"Chisholm DM, Mason DK: Labial salivary gland biopsy in Sjogren's disease. J Clin Pathol. 1968, 21: 656-660. 10.1136\/jcp.21.5.656.","journal-title":"J Clin Pathol"},{"key":"2793_CR12","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.1572-0241.2005.41217.x","volume":"100","author":"KR DeVault","year":"2005","unstructured":"DeVault KR, Castell DO: Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2005, 100: 190-200. 10.1111\/j.1572-0241.2005.41217.x.","journal-title":"Am J Gastroenterol"},{"key":"2793_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/rheumatology\/36.2.239","volume":"36","author":"CP Denton","year":"1997","unstructured":"Denton CP, Cailes JB, Phillips GD, Wells AU, Black CM, Bois RM: Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis. Br J Rheumatol. 1997, 36: 239-243. 10.1093\/rheumatology\/36.2.239.","journal-title":"Br J Rheumatol"},{"key":"2793_CR14","doi-asserted-by":"crossref","unstructured":"From the Centers for Disease Control. Occupational disease surveillance: carpal tunnel syndrome. JAMA. 1989, 262: 886-10.1001\/jama.262.7.886. 889","DOI":"10.1001\/jama.1989.03430070022009"},{"key":"2793_CR15","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1056\/NEJMra043898","volume":"353","author":"MM Kaplan","year":"2005","unstructured":"Kaplan MM, Gershwin ME: Primary biliary cirrhosis. N Engl J Med. 2005, 353: 1261-1273. 10.1056\/NEJMra043898.","journal-title":"N Engl J Med"},{"key":"2793_CR16","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/hep.1840180435","volume":"18","author":"PJ Johnson","year":"1993","unstructured":"Johnson PJ, McFarlane IG: Meeting report: International Autoimmune Hepatitis Group. Hepatology. 1993, 18: 998-1005. 10.1002\/hep.1840180435.","journal-title":"Hepatology"},{"key":"2793_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/00042737-200501000-00009","volume":"17","author":"AM Murdock","year":"2005","unstructured":"Murdock AM, Johnston SD: Diagnostic criteria for coeliac disease: time for change?. Eur J Gastroenterol Hepatol. 2005, 17: 41-43. 10.1097\/00042737-200501000-00009.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2793_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/978-1-60327-285-8_59","volume-title":"Diagnostic Criteria in Autoimmune Diseases","author":"BH Toh","year":"2008","unstructured":"Toh BH, Whittingham S, Alderuccio F: Autoimmune gastritis. Diagnostic Criteria in Autoimmune Diseases. Edited by: Shoenfeld Y, Ricard C, Gershwin ME. 2008, Humana Press, 315-321."},{"key":"2793_CR19","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1056\/NEJMra021194","volume":"348","author":"EN Pearce","year":"2003","unstructured":"Pearce EN, Farwell AP, Braverman LE: Thyroiditis. N Engl J Med. 2003, 348: 2646-2655. 10.1056\/NEJMra021194.","journal-title":"N Engl J Med"},{"key":"2793_CR20","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/BF00262092","volume":"14","author":"P Caramaschi","year":"1995","unstructured":"Caramaschi P, Biasi D, Manzo T, Carletto A, Poli F, Bambara LM: Anticentromere antibody--clinical associations. A study of 44 patients. Rheumatol Int. 1995, 14: 253-255. 10.1007\/BF00262092.","journal-title":"Rheumatol Int"},{"key":"2793_CR21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10067-005-0005-4","volume":"25","author":"K Pakunpanya","year":"2006","unstructured":"Pakunpanya K, Verasertniyom O, Vanichapuntu M, Pisitkun P, Totemchokchyakarn K, Nantiruj K, Janwityanujit S: Incidence and clinical correlation of anticentromere antibody in Thai patients. Clin Rheumatol. 2006, 25: 325-328. 10.1007\/s10067-005-0005-4.","journal-title":"Clin Rheumatol"},{"key":"2793_CR22","first-page":"260","volume":"192","author":"S Insua Vilarino","year":"1993","unstructured":"Insua Vilarino S, de la Hera Martinez M, Rodriguez-Valverde V, Merino Perez J, Alonso Valdivieso JL, Ruiz T: [The clinical spectrum of patients with anticentromere antibodies]. Rev Clin Esp. 1993, 192: 260-264.","journal-title":"Rev Clin Esp"},{"key":"2793_CR23","first-page":"362","volume":"64","author":"F Tubach","year":"1997","unstructured":"Tubach F, Hayem G, Elias A, Nicaise P, Haim T, Kahn MF, Meyer O: Anticentromere antibodies in rheumatologic practice are not consistently associated with scleroderma. Rev Rhum Engl Ed. 1997, 64: 362-367.","journal-title":"Rev Rhum Engl Ed"},{"key":"2793_CR24","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1365-2230.1994.tb01199.x","volume":"19","author":"HL Chan","year":"1994","unstructured":"Chan HL, Lee YS, Hong HS, Kuo TT: Anticentromere antibodies (ACA): clinical distribution and disease specificity. Clin Exp Dermatol. 1994, 19: 298-302. 10.1111\/j.1365-2230.1994.tb01199.x.","journal-title":"Clin Exp Dermatol"},{"key":"2793_CR25","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.semarthrit.2005.12.004","volume":"35","author":"M Ramos-Casals","year":"2006","unstructured":"Ramos-Casals M, Nardi N, Brito-Zeron P, Aguilo S, Gil V, Delgado G, Bove A, Font J: Atypical autoantibodies in patients with primary Sjogren syndrome: clinical characteristics and follow-up of 82 cases. Semin Arthritis Rheum. 2006, 35: 312-321. 10.1016\/j.semarthrit.2005.12.004.","journal-title":"Semin Arthritis Rheum"},{"key":"2793_CR26","first-page":"2238","volume":"28","author":"K Katano","year":"2001","unstructured":"Katano K, Kawano M, Koni I, Sugai S, Muro Y: Clinical and laboratory features of anticentromere antibody positive primary Sjogren's syndrome. J Rheumatol. 2001, 28: 2238-2244.","journal-title":"J Rheumatol"},{"key":"2793_CR27","first-page":"785","volume":"64","author":"P Caramaschi","year":"1997","unstructured":"Caramaschi P, Biasi D, Carletto A, Manzo T, Randon M, Zeminian S, Bambara LM: Sjogren's syndrome with anticentromere antibodies. Rev Rhum Engl Ed. 1997, 64: 785-788.","journal-title":"Rev Rhum Engl Ed"},{"key":"2793_CR28","first-page":"296","volume":"47","author":"SM Yan","year":"2008","unstructured":"Yan SM, Zeng XF, Zhao Y, Dong Y: [A clinical analysis of primary Sjogren's syndrome with anticentromere antibodies]. Zhonghua Nei Ke Za Zhi. 2008, 47: 296-299.","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"2793_CR29","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s00296-004-0568-4","volume":"26","author":"TC Hsu","year":"2006","unstructured":"Hsu TC, Chang CH, Lin MC, Liu ST, Yen TJ, Tsay GJ: Anti-CENP-H antibodies in patients with Sjogren's syndrome. Rheumatol Int. 2006, 26: 298-303. 10.1007\/s00296-004-0568-4.","journal-title":"Rheumatol Int"},{"key":"2793_CR30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1177\/096120339300200505","volume":"2","author":"PG Vlachoyiannopoulos","year":"1993","unstructured":"Vlachoyiannopoulos PG, Karassa FB, Karakostas KX, Drosos AA, Moutsopoulos HM: Systemic lupus erythematosus in Greece. Clinical features, evolution and outcome: a descriptive analysis of 292 patients. Lupus. 1993, 2: 303-312. 10.1177\/096120339300200505.","journal-title":"Lupus"},{"key":"2793_CR31","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/0002-9343(80)90462-3","volume":"69","author":"MJ Fritzler","year":"1980","unstructured":"Fritzler MJ, Kinsella TD: The CREST syndrome: a distinct serologic entity with anticentromere antibodies. Am J Med. 1980, 69: 520-526. 10.1016\/0002-9343(80)90462-3.","journal-title":"Am J Med"},{"key":"2793_CR32","first-page":"140","volume":"27","author":"P Fietta","year":"2009","unstructured":"Fietta P, Delsante G, Quaini F: Hematologic manifestations of connective autoimmune diseases. Clin Exp Rheumatol. 2009, 27: 140-154.","journal-title":"Clin Exp Rheumatol"},{"key":"2793_CR33","first-page":"S66","volume":"26","author":"M Voulgarelis","year":"2008","unstructured":"Voulgarelis M, Tzioufas AG, Moutsopoulos HM: Mortality in Sjogren's syndrome. Clin Exp Rheumatol. 2008, 26: S66-71.","journal-title":"Clin Exp Rheumatol"},{"key":"2793_CR34","volume-title":"Clin Rheumatol","author":"D Gulati","year":"2010","unstructured":"Gulati D, Kushner I, File E, Magrey M: Primary Sjogren's syndrome with anticentromere antibodies-a clinically distinct subset. Clin Rheumatol. 2010,"},{"key":"2793_CR35","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1002\/art.21922","volume":"54","author":"J Avouac","year":"2006","unstructured":"Avouac J, Sordet C, Depinay C, Ardizonne M, Vacher-Lavenu MC, Sibilia J, Kahan A, Allanore Y: Systemic sclerosis-associated Sjogren's syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients. Arthritis Rheum. 2006, 54: 2243-2249. 10.1002\/art.21922.","journal-title":"Arthritis Rheum"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar2958.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar2958\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar2958.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:56:51Z","timestamp":1728385011000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar2958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,13]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2010,4]]}},"alternative-id":["2793"],"URL":"https:\/\/doi.org\/10.1186\/ar2958","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,13]]},"assertion":[{"value":"8 January 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R47"}}